Search

Your search keyword '"Shin, Monica"' showing total 114 results

Search Constraints

Start Over You searched for: Author "Shin, Monica" Remove constraint Author: "Shin, Monica" Journal alzheimer's & dementia Remove constraint Journal: alzheimer's & dementia
114 results on '"Shin, Monica"'

Search Results

1. Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals

2. P4-333: ISSUES REGARDING [18 F]MK6240 REFERENCE REGION SELECTION BASED ON THE FULL KINETIC MODELING

3. IC-P-168: ISSUES REGARDING [18 F]MK6240 REFERENCE REGION SELECTION BASED ON THE FULL KINETIC MODELING

4. IC‐P‐023: UNBIASED ASSESSMENT OF GLOBAL AMYLOID LOAD AS DETERMINED BY VOXEL‐WISE RECEIVER OPERATING CHARACTERISTIC ANALYSIS

5. P4‐107: REGIONAL PATTERNS OF TAU DEPOSITION DRIVEN BY LOCAL AMYLOID ACCUMULATION RECAPITULATE BRAAK STAGES IN AD

6. IC‐P‐208: CORRELATION BETWEEN CSF T‐TAU AND P‐TAU WITH [ 18 F]MK6240 IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE

7. P1‐482: ASSOCIATION OF [ 18 F]MK6240 PET TAU BINDING WITH CLINICAL DIAGNOSIS, APOE4, COGNITION, AMYLOID, AGE, AND BRAAK STAGES ACROSS THE AD CLINICAL SPECTRUM

8. IC‐P‐055: REGIONAL PATTERNS OF TAU DEPOSITION DRIVEN BY LOCAL AMYLOID ACCUMULATION RECAPITULATE BRAAK STAGES IN AD

9. P3‐441: LOGICAL MEMORY DEFICITS ACROSS ALZHEIMER'S DISEASE SPECTRUM ARE ASSOCIATED WITH PATTERNS OF A TAU PROPAGATION PREDICTED BY BRAAK STAGING

10. P2‐462: UNBIASED ASSESSMENT OF GLOBAL AMYLOID LOAD AS DETERMINED BY VOXEL‐WISE RECEIVER OPERATING CHARACTERISTIC ANALYSIS

11. IC‐P‐213: [ 18 F]MK6240 PET TAU BINDING IN ATYPICAL AD AND NON‐AD TAUOPATHIES

13. IC‐P‐054: AMYLOID AND MICROGLIAL ACTIVATION SYNERGY LEADS TO HYPOMETABOLISM IN THE AD BRAIN: MICROPET LONGITUDINAL STUDY

14. P3‐338: AMYLOID AND MICROGLIAL ACTIVATION SYNERGY LEADS TO HYPOMETABOLISM IN AD BRAIN: MICROPET LONGITUDINAL STUDY

15. IC‐04‐05: IMAGING EPIGENETICS IN THE HUMAN BRAIN WITH THE NOVEL [ 11 C]MARTINOSTAT PET IN PRECLINICAL AD, MCI, AD, AND FRONTOTEMPORAL DEMENTIA INDIVIDUALS

17. O3‐01‐04: CORRELATION BETWEEN CSF T‐TAU AND P‐TAU WITH [ 18 F]MK6240 IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE

18. IC‐P‐103: LOGICAL MEMORY DEFICITS ACROSS ALZHEIMER'S DISEASE SPECTRUM ARE ASSOCIATED WITH PATTERNS OF TAU PROPAGATION PREDICTED BY BRAAK STAGING

19. O3‐10‐06: BRAIN EPIGENETIC CHANGES MEASURED WITH THE NOVEL [ 11 C]MARTINOSTAT PET MEDIATE THE EFFECTS OF AMYLOID AND TAU PET DEPOSITION ON COGNITION

20. [P3-425]: ELEVATED CSF LEVELS OF NEUROFILAMENT LIGHT CHAIN IS ASSOCIATED WITH GRAY MATTER NEURODEGENERATION IN BOTH HUMANS AND TRANSGENIC RAT MODEL OF ALZHEIMER's DISEASE

21. IN VIVO AND IN VITRO DEMONSTRATION OF [18F]THK5351 BINDING TO MONOAMINE OXIDASE–B IN THE HUMAN BRAIN

23. [P4-239]: FDG-PET POWER TO PREDICT MEMORY DECLINE IN ALZHEIMER's DISEASE DEPENDS ON DISEASE PHASE AND AMYLOID AND TAU STATUS

24. COMPARISON BETWEEN MONOAMINE OXIDASE B INHIBITION ON THE UPTAKE OF [18F]THK5351

25. [P2-413]: VOXEL-BASED POWER CALCULATION AND THRESHOLDS PREDICTIVE OF IMMINENT NEURODEGENERATION FOR PRECLINICAL ALZHEIMER's DISEASE CLINICAL TRIALS

27. [P3-321]: IN VIVO AND IN VITRO DEMONSTRATION OF [18 F]THK5351 BINDING TO MONOAMINE OXIDASE-B IN THE HUMAN BRAIN

28. FUNCTIONAL REGRESSION MODEL UNVEILS THAT GENE INTERACTION BETWEEN NCSTN (AMYLOID METABOLISM) AND MS4A4E (NEUROINFLAMMATION) DETERMINES AMYLOID LOAD SPECIFICALLY ON THE DMN

29. AMYLOID-BETA MODULATES CEREBRAL METABOLIC NETWORK IN RATS AND HUMANS

30. THE “A/T/N” SYSTEM: ADDED PREDICTIVE VALUE OF N BIOMARKERS OF PROGRESSION FROM MCI TO DEMENTIA OVER 2 AND 4 YEARS

31. [P4-050]: GRAPH-THEORY ANALYSIS SHOWS A HIGHLY EFFICIENT BUT REDUNDANT NETWORK IN MCI TAU PROPAGATION

32. [IC-P-149]: LACK OF SELF-AWARENESS OF COGNITIVE DEFICITS IN ALZHEIMER's DISEASE IS RELATED TO DECREASED METABOLISM IN THE POSTERIOR CINGULATE CORTEX

33. [IC-P-048]: ELEVATED CSF LEVELS OF NEUROFILAMENT LIGHT CHAIN IS ASSOCIATED WITH GRAY MATTER NEURODEGENERATION IN BOTH HUMANS AND TRANSGENIC RAT MODEL OF ALZHEIMER's DISEASE

34. PRECLINICAL ASSESSMENT OF KAL-ABP TARGET ENGAGEMENT AND EFFICACY USING PET, MRI AND CSF BIOMARKERS

35. [P3-412]: PET TAU AND AMYLOID SYNERGISM WITHIN THE DEFAULT MODE NETWORK DETERMINES THE CLINICAL STATUS IN THE PREDEMENTIA PHASE OF ALZHEIMER's DISEASE

36. [IC-P-045]: AMYLOID-BETA MODULATES CEREBRAL METABOLIC NETWORK IN RATS AND HUMANS

39. [P1-452]: COMBINED GLOBAL AND REGIONAL AMYLOID EFFECT ON THE DEFAULT MODE NETWORK LEADS TO COGNITIVE DECLINE

40. [IC-P-034]: GRAPH-THEORY ANALYSIS SHOWS A HIGHLY EFFICIENT BUT REDUNDANT NETWORK IN MCI TAU PROPAGATION

43. P4-198: Cognitive Decline is Driven By the Regional Synergism Between Amyloid Load and Hypometabolism in Mild Cognitive Impairment

44. IC-P-101: Synergism Between Baseline Amyloidosis and Neuronal Injury as Determinants of Learning Deficits in AD Transgenic Rat Model

45. IC‐P‐027: Amyloid‐Induced Microglial Activity in Thalamocortical Circuits Predicts Subsequent Cognitive Decline

46. P2-053: Amyloid-Induced Microglial Activity in Thalamocortical Circuits Predicts Subsequent Cognitive Decline

48. IC-P-099: Synergism Between Brain Amyloid Accumulation and Neuronal Injury in Cortical-Subcortical Circuits Causes Memory Declines in Animal Models

Catalog

Books, media, physical & digital resources